Indapamid Stada (Indapamide)

• Indapamide is used in the management of conditions related to fluid balance and vascular resistance.
• Hypertension: reduces systolic and diastolic blood pressure, helping to prevent cardiovascular complications.
• Edema associated with congestive heart failure: increases urinary output to lessen peripheral swelling and improve breathing.
• Edema due to renal disease: facilitates removal of excess fluid in patients with kidney‑related fluid retention.

• Indapamide inhibits the Na⁺/Cl⁻ cotransporter in the distal convoluted tubule of the nephron, reducing sodium and chloride reabsorption. This leads to increased diuresis, a modest vasodilatory effect, and a decrease in peripheral vascular resistance, collectively contributing to lower arterial blood pressure. The drug also modestly enhances prostaglandin synthesis, which further contributes to vasodilation, and it may improve endothelial function, supporting its antihypertensive action.

Indapamide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Increased urination: more frequent need to void.
• Dizziness or light‑headedness: especially when standing quickly.
• Headache: mild to moderate intensity.
• Electrolyte disturbances: low potassium or sodium levels.
• Nausea or abdominal discomfort.
• Fatigue: feeling unusually tired.

Serious or Rare Side Effects

• Severe dehydration: excessive fluid loss leading to low blood pressure.
• Acute electrolyte imbalance: dangerous hypokalemia or hyponatremia.
• Gout attacks: precipitated by increased uric acid.
• Allergic reactions: rash, itching, or swelling.
• Blood dyscrasias: rare cases of agranulocytosis or thrombocytopenia.
• Pancreatitis: inflammation of the pancreas.

• When prescribing Indapamide, clinicians should consider several safety measures to minimize risk.
• Monitor electrolytes: check serum potassium and sodium regularly during therapy.
• Assess renal function: evaluate kidney performance before initiation and adjust use in impairment.
• Avoid abrupt discontinuation: sudden stop may cause fluid retention and blood pressure rebound.
• Caution in gout: drug may precipitate gout flares, monitor uric acid.
• Pregnancy and lactation: use only if potential benefit justifies potential risk to fetus or infant.
• Store at ambient temperature: keep tablets in original container, protect from moisture and light.

Indapamide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Lithium: concurrent use may increase lithium levels and risk of toxicity.
• NSAIDs: may blunt diuretic effect and increase risk of renal impairment.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: additive blood pressure lowering may require dose adjustment.
• Corticosteroids: combined use can enhance potassium loss and electrolyte disturbances.
• Antidiabetic agents: diuretic may potentiate hypoglycemia, requiring glucose monitoring.